USA > UK based Eli Lilly is set to acquire USA based ARMO BioSciences for $1.6 billion

Eli Lilly logo For $50 per share or approximate value of $1.6 billion, UK based Eli Lilly is all set to acquire USA based ARMO BioSciences. ARMO BioSciences is a company that is working on a late stage immune oncology that is developing a pipeline of novel, proprietary product candidates that is designed to activate the immune system of cancer patients to recognize More …